126 related articles for article (PubMed ID: 23270324)
1. Aromatic sulfonamides containing a condensed piperidine moiety as potential oxidative stress-inducing anticancer agents.
Madácsi R; Kanizsai I; Fehér LZ; Gyuris M; Ozsvári B; Erdélyi A; Wölfling J; Puskás LG
Med Chem; 2013 Nov; 9(7):911-9. PubMed ID: 23270324
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new coumarin 3-(N-aryl) sulfonamides and their anticancer activity.
Reddy NS; Mallireddigari MR; Cosenza S; Gumireddy K; Bell SC; Reddy EP; Reddy MV
Bioorg Med Chem Lett; 2004 Aug; 14(15):4093-7. PubMed ID: 15225733
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
Mojzych M; Šubertová V; Bielawska A; Bielawski K; Bazgier V; Berka K; Gucký T; Fornal E; Kryštof V
Eur J Med Chem; 2014 May; 78():217-24. PubMed ID: 24681986
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and identification of heteroaromatic N-benzyl sulfonamides as potential anticancer agents.
Hopkins MD; Abebe FA; Scott KA; Ozmer GL; Sheir AA; Schroeder LJ; Sheaff RJ; Lamar AA
Org Biomol Chem; 2019 Sep; 17(36):8391-8402. PubMed ID: 31469373
[TBL] [Abstract][Full Text] [Related]
6. Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents.
Hu L; Li ZR; Wang YM; Wu Y; Jiang JD; Boykin DW
Bioorg Med Chem Lett; 2007 Mar; 17(5):1193-6. PubMed ID: 17197178
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of mono-indole-, bis-indole-, and tris-indole-based sulfonamides as potential anticancer agents.
Pingaew R; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Mol Divers; 2013 Aug; 17(3):595-604. PubMed ID: 23813045
[TBL] [Abstract][Full Text] [Related]
9. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
[TBL] [Abstract][Full Text] [Related]
10. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
[TBL] [Abstract][Full Text] [Related]
11. Parallel synthesis of novel antitumor agents: 1,2,3-triazoles bearing biologically active sulfonamide moiety and their 3D-QSAR.
Ou L; Han S; Ding W; Jia P; Yang B; Medina-Franco JL; Giulianotti MA; Chen JZ; Yu Y
Mol Divers; 2011 Nov; 15(4):927-46. PubMed ID: 21744258
[TBL] [Abstract][Full Text] [Related]
12. Arylsulfonyl-N,N-diethyl-dithiocarbamates: a novel class of antitumor agents.
Scozzafava A; Mastrolorenzo A; Supuran CT
Bioorg Med Chem Lett; 2000 Aug; 10(16):1887-91. PubMed ID: 10969992
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines.
Abdel Gawad NM; Amin NH; Elsaadi MT; Mohamed FMM; Angeli A; De Luca V; Capasso C; Supuran CT
Bioorg Med Chem; 2016 Jul; 24(13):3043-3051. PubMed ID: 27234893
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents.
Kachaeva MV; Hodyna DM; Semenyuta IV; Pilyo SG; Prokopenko VM; Kovalishyn VV; Metelytsia LO; Brovarets VS
Comput Biol Chem; 2018 Jun; 74():294-303. PubMed ID: 29698921
[TBL] [Abstract][Full Text] [Related]
17. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
Yurttaş L; Çiftçi GA
Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
[TBL] [Abstract][Full Text] [Related]
18. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH
J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V
Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
